Showing 61 - 80 of 84 trials – Showing only trials currently accepting patients
-
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Stanford is currently accepting patients for this trial. -
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
Stanford is currently accepting patients for this trial. -
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for Primary Central Nervous System Tumors
Stanford is currently accepting patients for this trial. -
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Stanford is currently accepting patients for this trial. -
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Stanford is currently accepting patients for this trial. -
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Stanford is currently accepting patients for this trial. -
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Stanford is currently accepting patients for this trial. -
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Stanford is currently accepting patients for this trial. -
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
Stanford is currently accepting patients for this trial. -
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
Stanford is currently accepting patients for this trial. -
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Stanford is currently accepting patients for this trial. -
A Study of SNDX-5613 in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Stanford is currently accepting patients for this trial. -
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Stanford is currently accepting patients for this trial. -
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Stanford is currently accepting patients for this trial. -
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Stanford is currently accepting patients for this trial. -
A Study of AL102 in Patients With Progressing Desmoid Tumors
Stanford is currently accepting patients for this trial. -
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Stanford is currently accepting patients for this trial. -
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases
Stanford is currently accepting patients for this trial. -
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
Stanford is currently accepting patients for this trial. -
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Stanford is currently accepting patients for this trial.